Home
Scholarly Works
Costs of dacomitinib versus placebo in pretreated...
Conference

Costs of dacomitinib versus placebo in pretreated unselected patients (pts) with advanced NSCLC: CCTG BR.26

Authors

Karim S; Ding K; Bradbury P; Ellis P; Mittman N; Sun XX; Millward M; Liu G; Sun S; Stockler MR

Volume

28

Publisher

OXFORD UNIV PRESS

Publication Date

September 1, 2017

Name of conference

42nd European-Society-for-Medical-Oncology Congress (ESMO)

Conference place

SPAIN, Madrid

Conference start date

September 8, 2017

Conference end date

September 12, 2017

Conference proceedings

ANNALS OF ONCOLOGY

ISSN

0923-7534

Contact the Experts team